<VariationArchive VariationID="3255221" VariationName="NM_004444.5(EPHB4):c.2389_2392del (p.Phe797fs)" VariationType="Deletion" Accession="VCV003255221" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3413991" VariationID="3255221">
      <GeneList>
        <Gene Symbol="EPHB4" FullName="EPH receptor B4" GeneID="2050" HGNC_ID="HGNC:3395" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100802565" stop="100827523" display_start="100802565" display_stop="100827523" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="100400186" stop="100425142" display_start="100400186" display_stop="100425142" Strand="-" />
          </Location>
          <OMIM>600011</OMIM>
        </Gene>
        <Gene Symbol="LOC126860124" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr7:100403701-100404900" GeneID="126860124" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100805443" stop="100807278" display_start="100805443" display_stop="100807278" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_004444.5(EPHB4):c.2389_2392del (p.Phe797fs)</Name>
      <CanonicalSPDI>NC_000007.14:100806511:TGAA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100806512" stop="100806515" display_start="100806512" display_stop="100806515" variantLength="4" positionVCF="100806511" referenceAlleleVCF="GTGAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="100404134" stop="100404137" display_start="100404134" display_stop="100404137" variantLength="4" positionVCF="100404133" referenceAlleleVCF="GTGAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F797fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.100404134_100404137del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.100404134_100404137del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.100806512_100806515del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.100806512_100806515del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_052671.1" sequenceAccession="NG_052671" sequenceVersion="1" change="g.26007_26010del">
            <Expression>NG_052671.1:g.26007_26010del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_084625.2" sequenceAccession="NG_084625" sequenceVersion="2" change="g.1170_1173del">
            <Expression>NG_084625.2:g.1170_1173del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004444.5" sequenceAccession="NM_004444" sequenceVersion="5" change="c.2389_2392del" MANESelect="true">
            <Expression>NM_004444.5:c.2389_2392del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004435.3" sequenceAccession="NP_004435" sequenceVersion="3" change="p.Phe797fs">
            <Expression>NP_004435.3:p.Phe797fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004444.5(EPHB4):c.2389_2392del (p.Phe797fs) AND Capillary malformation-arteriovenous malformation 2" Accession="RCV004595404" Version="1">
        <ClassifiedConditionList TraitSetID="45130">
          <ClassifiedCondition DB="MedGen" ID="C4748670">Capillary malformation-arteriovenous malformation 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27400125</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29905864</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30578106</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="45130" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40832" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation 2</ElementValue>
                <XRef ID="MONDO:0020785" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMAVM2</ElementValue>
                <XRef Type="MIM" ID="618196" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</Attribute>
                <XRef ID="NBK52764" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16307" />
                <XRef ID="16307" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21348050</ID>
                <ID Source="BookShelf">NBK52764</ID>
              </Citation>
              <XRef ID="C4748670" DB="MedGen" />
              <XRef ID="MONDO:0020785" DB="MONDO" />
              <XRef Type="MIM" ID="618196" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9874921" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_004444_4_EPHB4_c_2389_2392delTTCA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086693" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27400125</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29905864</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30578106</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with capillary malformation-arteriovenous malformation 2 (MIM#618196) and lymphatic malformation 7 (MIM#617300). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. There is intra-familial variability reported (PMID: 29905864, 27400125, 30578106). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Many other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPHB4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_23492</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004444.4:c.2389_2392delTTCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618196" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9874921" TraitType="Disease" MappingType="XRef" MappingValue="618196" MappingRef="OMIM">
        <MedGen CUI="C4748670" Name="Capillary malformation-arteriovenous malformation 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

